Verona Pharma plc (VRNA)
USD 40.06
(-3.84%)
USD 40.06
(-3.84%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -50.41 Million | -59.86 Million | -33.25 Million | -45.07 Million | -44.34 Million | -22.98 Million |
| Net Income | -54.57 Million | -68.7 Million | -55.56 Million | -65.14 Million | -51.4 Million | -30.62 Million |
| Depreciation & Amortization | 679.62 Thousand | 636 Thousand | 629 Thousand | 623 Thousand | 660.82 Thousand | 124.35 Thousand |
| Deferred income taxes | -486 Thousand | - | -17.42 Million | -635 Thousand | 5.7 Million | 5.82 Million |
| Stock-based compensation | 19.01 Million | 14.12 Million | 25.42 Million | 22.17 Million | 3.2 Million | 3.68 Million |
| Change in working capital | -13.95 Million | -10.73 Million | 13.44 Million | -2.11 Million | -45.89 Thousand | -138.31 Thousand |
| Other non-cash items | -1.09 Million | 4.82 Million | 239 Thousand | 18 Thousand | -2.46 Million | -1.85 Million |
| Investing Cash Flow | -165.3 Thousand | -29 Thousand | -12 Thousand | 9.71 Million | 49.56 Million | 6.7 Million |
| Investments in PPE | 4.07 | -29 Thousand | -12 Thousand | -82 Thousand | -369.74 Thousand | -340.06 Thousand |
| Acquisitions | - | - | - | - | 319.92 Thousand | 323.57 Thousand |
| Investment purchases | - | - | - | - | -10.41 Million | -75.75 Million |
| Sales/Maturities of investments | - | - | - | 9.79 Million | 59.17 Million | 81.67 Million |
| Other Investing Activities | - | -29 Thousand | -12 Thousand | 7.16 Million | 843.07 Thousand | 796.87 Thousand |
| Financing Cash Flow | 93.22 Million | 140.81 Million | -6.11 Million | 192.34 Million | -558.55 Thousand | 1.09 |
| Debt repayment | -38.84 Million | -5 Million | - | -4.93 Million | -426.00 | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -3.67 Million | -3.9 Million | -5.06 Million | - | - | - |
| Common Stock Issuance | 54.38 Million | 149.79 Million | 733 Thousand | 200.15 Million | - | - |
| Other Financing Activities | 77.69 Million | 3.83 Million | -1.78 Million | -2.88 Million | -558.13 Thousand | - |
| Accounts receivables | -1.1 Million | 3.96 Million | -6.92 Million | 773.97 Thousand | -3.94 Million | - |
| Accounts payables | 487.88 Thousand | -7.14 Million | 9.86 Million | -1.39 Million | -1.74 Million | - |
| Inventory | 1.00 | -3.96 Million | 6.92 Million | -773.97 Thousand | 4.24 Million | - |
| Other working capital | -13.33 Million | -3.59 Million | 3.57 Million | -715 Thousand | 1.39 Million | -138.31 Thousand |
| Cash at beginning of period | 227.82 Million | 148.38 Million | 187.98 Million | 30.42 Million | 25.94 Million | 39.89 Million |
| Cash at end of period | 271.77 Million | 227.82 Million | 148.38 Million | 187.98 Million | 30.07 Million | 25.1 Million |
| Capital Expenditure | 4.07 | -29 Thousand | -12 Thousand | -82 Thousand | -369.74 Thousand | -340.06 Thousand |
| Effect of forex changes on cash | 1.29 Million | -1.48 Million | -223 Thousand | 581 Thousand | -528.39 Thousand | 1.48 Million |
| Net cash flow / Change in cash | 43.94 Million | 79.44 Million | -39.6 Million | 157.55 Million | 4.13 Million | -14.79 Million |
| Free Cash Flow | -50.41 Million | -59.89 Million | -33.26 Million | -45.15 Million | -44.71 Million | -23.32 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -42.89 Million | -70.91 Million | -25.77 Million | -54.57 Million | -14.25 Million | -14.68 Million |
| Depreciation & Amortization | 1.04 Million | 270.3 Thousand | 262.84 Thousand | 679.62 Thousand | 209.8 Thousand | 155 Thousand |
| Deferred income taxes | - | - | - | -486 Thousand | -3.44 Million | 1.01 Million |
| Stock-based compensation | 7.65 Million | 15.59 Million | 4.25 Million | 19.01 Million | 4.56 Million | 5.07 Million |
| Change in working capital | -41.29 Million | 34.02 Million | 7.26 Million | -13.95 Million | 132.05 Thousand | -4.33 Million |
| Other non-cash items | 12.84 Million | 13.11 Million | 4.13 Million | -1.09 Million | 2.36 Million | 48 Thousand |
| Investing Cash Flow | 13.00 | -29.02 Thousand | -15.99 Thousand | -165.3 Thousand | -37.06 Thousand | - |
| Investments in PPE | 45.01 Thousand | -29.02 Thousand | -15.99 Thousand | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -45 Thousand | - | -16 Thousand | - | - | - |
| Financing Cash Flow | -7.13 Million | 166.51 Million | -2.75 Million | 93.22 Million | 24.06 Million | 48 Thousand |
| Debt repayment | -167.99 Million | -167.99 Million | - | -38.84 Million | -28.8 Million | -19.11 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 3.99 Million | -1.16 Million | -2.83 Million | -3.67 Million | -3.67 Million | - |
| Common Stock Issuance | -816.25 Thousand | 3.57 Million | -2.75 Million | 54.38 Million | -4.73 Million | -64.25 Thousand |
| Other Financing Activities | 157.67 Million | -5.04 Million | -3.93 Million | 77.69 Million | 57.61 Million | 131.37 Thousand |
| Accounts receivables | -14.1 Million | 7.78 Million | -584.66 Thousand | -1.1 Million | -1.03 Million | 312.09 Thousand |
| Accounts payables | 2.67 Million | -498.04 Thousand | 1.25 Million | 487.88 Thousand | 2.58 Million | -1.67 Million |
| Inventory | -4.31 Million | - | - | 1.00 | -1.00 | -312.09 Thousand |
| Other working capital | -33.33 Million | 26.73 Million | 6.59 Million | -13.33 Million | -1.41 Million | -2.66 Million |
| Cash at beginning of period | 404.59 Million | 254.88 Million | 271.77 Million | 227.82 Million | 257.36 Million | 270.72 Million |
| Cash at end of period | 336.04 Million | 404.59 Million | 254.88 Million | 271.77 Million | 271.77 Million | 257.36 Million |
| Capital Expenditure | 45.01 Thousand | -29.02 Thousand | -15.99 Thousand | - | - | - |
| Effect of forex changes on cash | 1.18 Million | 16 Thousand | -141 Thousand | 1.29 Million | 796 Thousand | -682 Thousand |
| Net cash flow / Change in cash | -68.55 Million | 149.71 Million | -16.89 Million | 43.94 Million | 14.4 Million | -13.36 Million |
| Free Cash Flow | -62.6 Million | -16.78 Million | -13.98 Million | -50.41 Million | -10.42 Million | -12.72 Million |
TRM
ATISHAY
VERK
TORVF
MNAP
GLKFF